Drug intelligence / Profile preview

standardised 5-grass pollen allergen extract

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

Standardised 5-grass pollen allergen extract is a form of sublingual immunotherapy (SLIT) used to treat grass pollen-induced allergic rhinoconjunctivitis. It consists of extracts from five common types of grass pollens: Sweet Vernal (Anthoxanthum odoratum), Orchard (Dactylis glomerata), Perennial Rye (Lolium perenne), Timothy (Phleum pratense), and Kentucky Blue Grass (Poa pratensis). [1] Administered as drops under the tongue, the treatment works by gradually exposing the immune system to these allergens, which induces immunological tolerance, reduces the allergic response, and alleviates symptoms. [4, 7] The provided clinical trial context mentions ALK-Abelló as the sponsor, which is notable because ALK's primary grass pollen products (Grastek/Grazax) are based on a single grass, whereas the 5-grass mix is more commonly associated with Stallergenes Greer's products like Oralair (a tablet) and Staloral (drops). [3, 14, 20, 24] A recent Phase III trial by ALK, named RHAPSODY, has specifically evaluated a 5-grass-pollen SLIT drop formulation. [12]

Brand names
Staloral
Other names
5-grass mix SLIT-drops

Beyond the preview

Go deeper on standardised 5-grass pollen allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on standardised 5-grass pollen allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call